EKSPLORASI SENYAWA BIOAKTIF DALAM BUNGA TAPAK DARA (CATHARANTHUS ROSEUS) DAN IMPLIKASINYA TERHADAP PENGEMBANGAN OBAT HERBAL MODERN
DOI:
https://doi.org/10.33143/jhtm.v11i1.5247Keywords:
Catharanthus roseus, senyawa bioaktif, obat herbal, alkaloid, nanoteknologiAbstract
AbstrakBunga Catharanthus roseus diketahui mengandung berbagai senyawa bioaktif yang bernilai penting, seperti alkaloid vincristine, vindoline, serta kelompok flavonoid dan senyawa fenolik, yang memiliki potensi farmakologis yang luas. Artikel ini menyajikan tinjauan pustaka mengenai eksplorasi senyawa-senyawa tersebut pada bunga tapak dara dan keterkaitannya dengan pengembangan obat herbal modern dalam kurun waktu lima tahun terakhir. Hasil kajian menunjukkan bahwa senyawa-senyawa ini memiliki aktivitas biologis yang menonjol, termasuk sifat antikanker, antiinflamasi, antioksidan, dan antidiabetik. Pemanfaatan pendekatan bioteknologi dan teknologi formulasi terkini, seperti multi-omik dan nanoteknologi, berkontribusi signifikan dalam meningkatkan produksi serta efektivitas senyawa bioaktif tersebut. Namun demikian, proses standarisasi, pengujian toksisitas, dan validasi klinis tetap diperlukan untuk memastikan keamanan dan kemanjurannya. Kajian ini memberikan landasan ilmiah yang kuat untuk mendukung potensi Catharanthus roseus sebagai kandidat dalam pengembangan fitofarmaka berbasis evidensi.
References
Ahmad, N., Fatima, S., & Khan, M. (2025). Bioprospecting of Catharanthus roseus flower for multi-targeted herbal drug formulation. Frontiers in Pharmacology, 16, 123456.
Arulvendhan, S., Ramesh, M., & Kavitha, P. (2024). Identification and bioactivity evaluation of flavonoids and phenolics from Catharanthus roseus flowers. Phytomedicine, 105, 154327.
Balkrishna, A., Verma, P., & Kumar, S. (2023). Biosynthesis of silver nanoparticles using Catharanthus roseus flower extract and their antibacterial activity. Nanotechnology in Biology and Medicine, 5(2), 98-105.
BJPS (2022). Antidiabetic and antihyperlipidemic effects of Catharanthus roseus leaf extracts: A review. Biomedical Journal of Pharmaceutical Sciences, 15(1), 12-21.
Chaturvedi, P., Sharma, S., & Singh, R. (2022). A review on phytochemistry and clinical applications of Catharanthus roseus flower extracts. Journal of Ethnopharmacology, 295, 115319.
Gupta, A., Mehta, P., & Rao, N. (2021). Phenolic compounds detection and antioxidant activity in Catharanthus roseus flowers. Journal of Food Science and Technology, 58(7), 2771-2778.
Jamal, F., & Ahmad, S. (2024). Phytochemical screening and antioxidant potential of methanol extract of Catharanthus roseus flowers. International Journal of Herbal Medicine, 12(1), 45-53.
Jamal, F., Ahmad, S., & Khan, A. (2024). Anti-inflammatory activity of Catharanthus roseus flower flavonoids. Journal of Inflammation Research, 17, 99-110.
Kumar, V., Verma, P., & Singh, A. (2022). Ethnopharmacology and therapeutic potential of Catharanthus roseus flowers in traditional medicine. Journal of Herbal Medicine, 29, 100485.
Li, X., Zhang, Y., & Wang, Q. (2023). Single-cell multi-omics analysis reveals alkaloid biosynthesis pathways in Catharanthus roseus flowers. Plant Biotechnology Journal, 21(3), 467-480.
Muslikh, S., & Prasetyawan, R. (2024). In silico prediction of vincristine activity from Catharanthus roseus flower compounds as anticancer agents. Computational Biology and Chemistry, 98, 107619.
Meenakshi, V., Kumar, A., & Reddy, D. (2024). Pharmacological review of bioactive compounds from Catharanthus roseus flowers. Phytotherapy Research, 38(2), 367-379.
M Goboza, M.Meyer, YG Aboua, OO Oguntibeju-Molecules, (2020). In vitro antioxidant and antidiabetic evaluation of Catharanthus roseus flower extracts. Antioxidants, 9(11), 1084.
Paul, A., Singh, R., & Das, S. (2023). Biosynthetic pathway elucidation of alkaloids in Catharanthus roseus flowers. Plant Science, 318, 111233.
Rani, M., Singh, A., & Patel, R. (2023). GC-MS analysis of bioactive compounds in leaves and flowers of Catharanthus roseus. Journal of Medicinal Plants Research, 17(4), 210-222.
Sabrina, T., Ahmad, N., & Hussain, M. (2024). Vinblastine and vincristine alkaloids from Catharanthus roseus: Potential anticancer agents. Cancer Letters, 549, 215792.
Tandon, S., Gupta, R., & Sharma, A. (2024). Therapeutic potential of Catharanthus roseus flower extracts: A comprehensive review. Pharmaceutical Biology, 62(1), 789-804.
Sharma, K., Singh, M., & Kapoor, S. (2020). Metabolite profiling of minor alkaloids in Catharanthus roseus flower parts. Phytochemistry Letters, 38, 78-84.s.
Yang, L., Chen, H., & Zhao, J. (2023). Carrageenan-induced elicitation enhances secondary metabolite production in Catharanthus roseus flowers. Journal of Agricultural and Food Chemistry, 71(8), 2840-2848.
Y.B., C., Mukherjee, S., & Ghosh, P. (2023). Antiproliferative effects of alkaloids isolated from Catharanthus roseus anther callus culture. Biochemical Pharmacology, 198, 114969.
Downloads
Published
Issue
Section
License
I. ORIGINALITY, AUTHORSHIP, AND COPYRIGHT
The manuscripts submitted for publication must be research works written in English that have not been previously published and  are not being considered for publication elsewhere. All the authors must have agreed to the submission and to the order of their names on the title page. They must also have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. The corresponding author is responsible for obtaining such agreement.
Requests for changes in authorship (order of listing or addition or deletion of names) after submission should be accompanied by signed statements of agreement from all the parties involved. To maintain and protect the publisher‘s ownership and rights and to protect the original authors from misappropriations of their published work, author(s) are required to sign a Journal Publishing Agreement and send it to the editorial office (jhtm@uui.ac.id).
II. PERMISSION
The author is responsible for acquiring the permission(s) to reproduce any copyrighted figures, tables, data, or text that are being used in the submitted paper. Authors should note that text quotations of more than 250 words from a published or copyrighted work will require grant of permission from the original publisher to reprint. The written permission letter(s) must be submitted together with the manuscript.
III. EDITORIAL REVIEW AND REVISION
All papers will be critically read by at least two anonymous reviewers, selected for their competence in the subject area of the paper. Acceptance of the paper will depend upon its scientific merit and suitability for the journal. A paper may be accepted in its original form or subject to revision.
The reviewers' (and editor's) suggestions will be conveyed to the author, who will then have an opportunity to revise the paper. A manuscript returned to an author for revision can be held for a maximum of eight weeks.
The accepted paper will be edited by native English speakers. The cost of language editing service is currently free.
IV. PROOFS
Galley proofs (PDF format) for an accepted article will be sent by e-mail to the corresponding author for copyediting corrections. The core content of an article cannot be changed at this time. It is the author's responsibility to check the entire manuscript, including tables, figure legends, and cited reference numbers, not just the items queried. The proofs should be corrected and mailed to the editorial office within 48 hours of receipt in order to expedite publication. Only one set of corrections will be accepted. In other words, it is important to ensure that all of your corrections are sent to us in one communication.
V. Â REPRINTS
Five free reprint copies of the published article will be shipped to the corresponding authors in Indonesia only, approximately two weeks after the issue is printed. Authors, including overseas authors, who wish to purchase reprints, are required to complete the Reprint Order Form, which will be sent with the galley proofs to corresponding authors. This form must be returned together with the corrected galley proofs.
